Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a RSV challenge study of oral JNJ-53718678 in healthy adults
2014-005041-41Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing JNJ-53718678 with Placebo (2 arms). Primary endpoint: Area Under the Viral Load-time Curve (VL AUC). Started Mar 2015; status: completed.
02
Drugs
rilematovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2014-005041-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005041-41.